M. Saiki et al., Adenovirus-mediated gene transfer of a truncated form of fibroblast growthfactor receptor inhibits growth of glioma cells both in vitro and in vivo, J NEURO-ONC, 44(3), 1999, pp. 195-203
Basic fibroblast growth factor (FGF-2) and high affinity FGF receptor (FGFR
) have been detected in the nucleus as well as the cytoplasm of many human
gliomas, and are known to stimulate cellular proliferation and angiogenesis
in the tumors. To investigate the effects of inactivation of FGFR on the g
rowth of malignant gliomas, we constructed a replication-deficient recombin
ant adenovirus vector encoding a truncated form of chicken FGFR1 (AxCA Delt
a FR). AxCA Delta FR-infected cells were confirmed to express truncated FGF
R protein by immunoblotting and FGF-2-dependent clonogenicity of NIH3T3 cel
ls was suppressed by infection with this virus vector. Then human malignant
glioma cell lines U-251MG and T98G, both of which have been reported to ex
press FGF-2 and FGFR, were infected with AxCA Delta FR. These infected cell
s showed nuclear as well as cytoplasmic expression of a truncated FGFR prot
ein. Proliferation rate and the ability to form colonies in soft agar of th
e cells infected with this virus vector were significantly suppressed compa
red with those of uninfected and lacZ-expressing adenovirus-infected cells.
Moreover, intratumoral injection of AxCA Delta FR significantly suppressed
the subcutaneous tumor growth of the glioma cells in nude mice. We conclud
ed that inactivation of the cytoplasmic and nuclear FGFR using this truncat
ed FGFR-expressing adenovirus vector can inhibit the growth of malignant gl
iomas both in vitro and in vivo.